• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过铁代谢平衡来维持心脏内环境稳定。

Keeping heart homeostasis in check through the balance of iron metabolism.

机构信息

Faculty of Medicine, Department of Physiology, University of Prishtina, Prishtina, Kosovo.

出版信息

Acta Physiol (Oxf). 2020 Jan;228(1):e13324. doi: 10.1111/apha.13324. Epub 2019 Jun 19.

DOI:10.1111/apha.13324
PMID:31162883
Abstract

Highly active cardiomyocytes need iron for their metabolic activity. In physiological conditions, iron turnover is a delicate process which is dependent on global iron supply and local autonomous regulatory mechanisms. Though less is known about the autonomous regulatory mechanisms, data suggest that these mechanisms can preserve cellular iron turnover even in the presence of systemic iron disturbance. Therefore, activity of local iron protein machinery and its relationship with global iron metabolism is important to understand cardiac iron metabolism in physiological conditions and in cardiac disease. Our knowledge in this respect has helped in designing therapeutic strategies for different cardiac diseases. This review is a synthesis of our current knowledge concerning the regulation of cardiac iron metabolism. In addition, different models of cardiac iron dysmetabolism will be discussed through the examples of heart failure (cardiomyocyte iron deficiency), myocardial infarction (acute changes in cardiac iron turnover), doxorubicin-induced cardiotoxicity (cardiomyocyte iron overload in mitochondria), thalassaemia (cardiomyocyte cytosolic and mitochondrial iron overload) and Friedreich ataxia (asymmetric cytosolic/mitochondrial cardiac iron dysmetabolism). Finally, future perspectives will be discussed in order to resolve actual gaps in knowledge, which should be helpful in finding new treatment possibilities in different cardiac diseases.

摘要

高活性心肌细胞需要铁来进行代谢活动。在生理条件下,铁的周转是一个微妙的过程,依赖于全身的铁供应和局部自主调节机制。尽管关于自主调节机制的了解较少,但数据表明,即使存在系统性铁紊乱,这些机制也可以维持细胞内铁的周转。因此,了解局部铁蛋白机器的活性及其与全身铁代谢的关系,对于理解生理条件下和心脏疾病中的心脏铁代谢是很重要的。我们在这方面的知识有助于设计针对不同心脏疾病的治疗策略。这篇综述是对我们目前关于心脏铁代谢调节的知识的综合。此外,还将通过心力衰竭(心肌细胞铁缺乏)、心肌梗死(心脏铁周转的急性变化)、多柔比星诱导的心脏毒性(线粒体中的心肌细胞铁过载)、地中海贫血(心肌细胞胞浆和线粒体铁过载)和弗里德赖希共济失调(不对称的胞浆/线粒体心脏铁代谢紊乱)的例子,讨论不同的心脏铁代谢紊乱模型。最后,将讨论未来的展望,以解决知识的实际差距,这有助于在不同的心脏疾病中找到新的治疗可能性。

相似文献

1
Keeping heart homeostasis in check through the balance of iron metabolism.通过铁代谢平衡来维持心脏内环境稳定。
Acta Physiol (Oxf). 2020 Jan;228(1):e13324. doi: 10.1111/apha.13324. Epub 2019 Jun 19.
2
Iron and the heart: A paradigm shift from systemic to cardiomyocyte abnormalities.铁与心脏:从系统性异常到心肌细胞异常的范式转变。
J Cell Physiol. 2019 Dec;234(12):21613-21629. doi: 10.1002/jcp.28820. Epub 2019 May 20.
3
[Iron and stable ischemic heart disease - lessons from heart failure].[铁与稳定性缺血性心脏病——心力衰竭的教训]
G Ital Cardiol (Rome). 2019 Oct;20(10):559-573. doi: 10.1714/3228.32055.
4
Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.铁蛋白重链作为二甲双胍对阿霉素诱导的心肌细胞线粒体损伤预防作用的主要介质。
Free Radic Biol Med. 2014 Feb;67:19-29. doi: 10.1016/j.freeradbiomed.2013.11.003. Epub 2013 Nov 11.
5
Mitochondrial membrane transporters and metabolic switch in heart failure.心力衰竭中心肌线粒体膜转运体与代谢转换
Heart Fail Rev. 2019 Mar;24(2):255-267. doi: 10.1007/s10741-018-9756-2.
6
Influence of mitochondrial and systemic iron levels in heart failure pathology.线粒体和全身铁水平对心力衰竭病理的影响。
Heart Fail Rev. 2019 Sep;24(5):647-659. doi: 10.1007/s10741-019-09788-z.
7
Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure.铁调节蛋白可确保心肌细胞中的铁供应,以防止心力衰竭。
Eur Heart J. 2017 Feb 1;38(5):362-372. doi: 10.1093/eurheartj/ehw333.
8
Brain iron homeostasis.脑铁稳态
Dan Med Bull. 2002 Nov;49(4):279-301.
9
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism.新生大鼠心室肌细胞中的铁调素缺乏靶向线粒体和脂质代谢。
Free Radic Biol Med. 2014 Aug;73:21-33. doi: 10.1016/j.freeradbiomed.2014.04.016. Epub 2014 Apr 18.
10
New Insights into the Hepcidin-Ferroportin Axis and Iron Homeostasis in iPSC-Derived Cardiomyocytes from Friedreich's Ataxia Patient.成纤维细胞生长因子 21 改善糖尿病心肌病心肌能量代谢和心脏功能的机制研究
Oxid Med Cell Longev. 2019 Mar 27;2019:7623023. doi: 10.1155/2019/7623023. eCollection 2019.

引用本文的文献

1
Ferroptosis in NAFLD: insights and the therapeutic potential of exercise.非酒精性脂肪性肝病中的铁死亡:见解与运动的治疗潜力
Front Med (Lausanne). 2025 Mar 26;12:1462145. doi: 10.3389/fmed.2025.1462145. eCollection 2025.
2
Advances in Chinese herbal medicine in modulating mitochondria to treat myocardial ischemia-reperfusion injury: a narrative review.中药在调节线粒体治疗心肌缺血再灌注损伤方面的研究进展:一项叙述性综述
Cardiovasc Diagn Ther. 2025 Feb 28;15(1):207-232. doi: 10.21037/cdt-24-346. Epub 2025 Feb 25.
3
Cardiac injury caused by iron overload in thalassemia.
地中海贫血中铁过载所致的心脏损伤。
Front Pediatr. 2025 Jan 27;13:1514722. doi: 10.3389/fped.2025.1514722. eCollection 2025.
4
Dexmedetomidine preconditioning attenuates ferroptosis in myocardial ischemia-reperfusion injury via α2 adrenergic receptor activation.右美托咪定预处理通过激活α2肾上腺素能受体减轻心肌缺血再灌注损伤中的铁死亡。
Heliyon. 2024 Oct 22;10(21):e39697. doi: 10.1016/j.heliyon.2024.e39697. eCollection 2024 Nov 15.
5
Cardiomyocyte-specific overexpression of FPN1 diminishes cardiac hypertrophy induced by chronic intermittent hypoxia.心肌细胞特异性过表达 FPN1 可减轻慢性间歇性低氧诱导的心肌肥大。
J Cell Mol Med. 2024 Jul;28(14):e18543. doi: 10.1111/jcmm.18543.
6
Involvement of Ferroptosis Induction and Oxidative Phosphorylation Inhibition in the Anticancer-Drug-Induced Myocardial Injury: Ameliorative Role of Pterostilbene.铁死亡诱导和氧化磷酸化抑制在抗癌药物所致心肌损伤中的作用:紫檀芪的改善作用
Int J Mol Sci. 2024 Mar 5;25(5):3015. doi: 10.3390/ijms25053015.
7
Assessment of the Impact of Carvedilol Administered Together with Dexrazoxan and Doxorubicin on Liver Structure and Function, Iron Metabolism, and Myocardial Redox System in Rats.评估卡维地洛与右雷佐生和多柔比星联合给药对大鼠肝脏结构和功能、铁代谢以及心肌氧化还原系统的影响。
Int J Mol Sci. 2024 Feb 13;25(4):2219. doi: 10.3390/ijms25042219.
8
Protective effects of Shen Yuan Dan on myocardial ischemia-reperfusion injury via the regulation of mitochondrial quality control.参元丹通过调节线粒体质量控制对心肌缺血再灌注损伤的保护作用
Cardiovasc Diagn Ther. 2023 Apr 28;13(2):395-407. doi: 10.21037/cdt-23-86. Epub 2023 Apr 24.
9
MiR-130a-3p regulates FUNDC1-mediated mitophagy by targeting GJA1 in myocardial ischemia/reperfusion injury.微小RNA-130a-3p通过靶向缝隙连接蛋白1在心肌缺血/再灌注损伤中调节FUNDC1介导的线粒体自噬。
Cell Death Discov. 2023 Feb 25;9(1):77. doi: 10.1038/s41420-023-01372-7.
10
Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases.梳理心血管疾病中铁死亡的当前研究并确定热点
Front Cardiovasc Med. 2022 Nov 4;9:1046377. doi: 10.3389/fcvm.2022.1046377. eCollection 2022.